Comparative considerations for cartridges and staked-needle prefilled syringes in large-volume autoinjector applications

October 07 2026

Summary

As large-volume therapies advance through clinical development, primary container selection becomes an increasingly important consideration for autoinjector development. This poster, presented by Thomas James at the 2026 Parenteral Drug Association (PDA) Universe of Prefilled Syringes and Injection Devices conference, compares cartridges and staked-needle prefilled syringes (PFSs), examining how each format can influence device ergonomics, fluid-path configuration, packaging and supply-chain efficiency, drug and formulation compatibility, and clinical development pathways.

Rather than identifying one preferred format, the poster highlights the distinct trade-offs that should be considered when aligning the primary container with the needs of the drug, device, patient, and supply chain.

 

Key takeaways

  • Primary container choice has implications beyond containment. The selected format can influence device design, usability, development strategy, manufacturing, and supply-chain considerations.
  • Cartridges can support a more compact device architecture at higher volumes
  • Cartridge architecture provides greater fluid-path configurability, because the needle is separate from the primary container
  • PFSs can offer advantages during clinical development. A PFS can support manual administration in early clinical studies while autoinjector development proceeds in parallel.
  • There is no universal choice, with the appropriate container depending on the specific requirements of the drug, device, patient, development program, and supply chain

 

Document details

  • Format: Scientific poster
  • Author/Spokesperson: Thomas James, Customer Solutions Manager
  • Page count: 1 page
  • Estimated read time: 5-10 minutes
[.jpg] PFS vs Cartridge Container Comparison in LV Autoinjectors PDA Universe 2026 Poster Preview Image